Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine.
about
Prevention of non-enzymatic glycosylation (glycation): Implication in the treatment of diabetic complicationA novel mechanism for antiglycative action of limonene through stabilization of protein conformation.Prolonged glycation of hen egg white lysozyme generates non amyloidal structures.Antidiabetic Compounds in Syzygium cumini Decoction and Ready to Serve Herbal Drink.Effect of oxytocin injection to milching buffaloes on its content & stability in milk.Analysis of glycation induced protein cross-linking inhibitory effects of some antidiabetic plants and spices.Anti-diabetic effects of the Indian indigenous fruit Emblica officinalis Gaertn: active constituents and modes of action.Prevention of protein glycation by natural compounds.Antiglycation therapy: Discovery of promising antiglycation agents for the management of diabetic complications.Methylglyoxal in Metabolic Disorders: Facts, Myths, and Promises.Ocular inflammation and endoplasmic reticulum stress are attenuated by supplementation with grape polyphenols in human retinal pigmented epithelium cells and in C57BL/6 mice.Protein glycation inhibitory activity and antioxidant capacity of clove extract.Inhibition of nonenzymatic protein glycation by pomegranate and other fruit juices.Evaluation of antioxidants and argpyrimidine in normal and cataractous lenses in north Indian population.Antiglycative effect of fruit and vegetable seed extracts: inhibition of AGE formation and carbonyl-trapping abilities.Modeling the scavenging activity of ellagic acid and its methyl derivatives towards hydroxyl, methoxy, and nitrogen dioxide radicals.Antiamyloidogenic Effects of Ellagic Acid on Human Serum Albumin Fibril Formation Induced by Potassium Sorbate and Glucose.Attenuation of diabetic retinopathy in rats by ellagic acid through inhibition of AGE formation.Mechanism of capsaicin inhibition of aldose reductase activity.Hydroxy methoxy benzaldehyde from Sesbania grandilfora inhibits the advanced glycation end products (AGEs)-mediated fibrillation in hemoglobin.Aspartic acid functions as carbonyl trapper to inhibit the formation of advanced glycation end products by chemical chaperone activity.Anti-prediabetic effect of rose hip (Rosa canina) extract in spontaneously diabetic Torii rats.Inhibition of protein glycation by procyanidin-B2 enriched fraction of cinnamon: delay of diabetic cataract in rats.
P2860
Q26751110-6327B15C-866F-4FDE-AA9C-4035D915958BQ30352232-94C0CEFC-2B08-464D-B5E6-F47AB785E3F2Q30353896-D397EAFD-066A-4E4D-9306-C48B700D8FDBQ33716244-496DE0B2-9869-4546-AF37-6F551AB55C86Q34186172-3F61FCFB-D043-4A4F-ADF7-3D4F14B781F1Q35657285-8DD8B72B-07F7-4930-9E03-243CF4B9F24EQ38191793-A7A19568-36A5-4004-BE96-9D68462DB6E5Q38358965-B8AE266C-F558-48E7-A658-84923C2B993DQ38411686-E608ABDB-3684-41F3-A061-8B90355D25D6Q38956425-7B1791AE-F0D5-4FE0-A751-AD1954297C27Q39008193-5141C9AE-72FD-403A-BA12-74905722332BQ39495740-D59CD6B8-CDBB-4DEE-B2C5-3BE75F74E5C7Q40981408-35DC0B6F-C52C-40BD-AC96-3DD02B72ADEEQ41039997-16E0DD8F-A609-4612-A185-B0AE9173E35BQ45253199-F87A7984-DBAC-4FAD-8DFB-E74BBD5E9F54Q45256074-7D505B03-3200-404D-B957-5EA97494F8C6Q46503044-C4456F4A-8EEC-4038-9327-B063787474FEQ48032100-A95DEFF0-139D-424F-B4C6-3E1157C39D38Q48300940-658B2599-443B-4CD4-B16D-A2BFA8B9CB41Q50213064-BD3D4B92-4918-415C-BF08-8CBA9235DE1AQ50437752-E4B68918-28BA-4156-B4F0-1660C8080475Q51144063-9E1EEE49-9D97-4E5A-B1E6-99EAA0D4CC51Q54735055-11401C98-53CD-4996-A9D1-F7937855A797
P2860
Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine.
@ast
Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine.
@en
Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine.
@nl
type
label
Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine.
@ast
Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine.
@en
Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine.
@nl
prefLabel
Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine.
@ast
Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine.
@en
Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine.
@nl
P2860
P356
P1433
P1476
Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine
@en
P2093
Chandrasekhar Akileshwari
Puppala Muthenna
P2860
P304
P356
10.1042/BJ20110846
P407
P50
P577
2012-02-01T00:00:00Z